Find your next paid study

Northwell HealthNCT04005378

Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services

The Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services (BICEPS) study aims to understand the early stages of psychotic disorders like Schizo…

Schizophrenia Spectrum and Other Psychotic DisordersSchizophreniaDelusional Disorder+4 more

Beth Israel Deaconess Medical CenterNCT06740383

~$10 – $750

PsychosisProdromal SchizophreniaProdromal Symptoms

Targeting Processing Speed Deficits to Improve Social Functioning and Lower Psychosis Risk in Adolescents at Clinical High Risk for Psychosis

This 10 week intervention, Specific Cognitive Remediation with Surround (or SCORES), is designed to target processing speed, a cognitive domain related directl…

Northwell HealthNCT05131035

Phase 4

Early-phase Schizophrenia: Practice-based Research to Improve Outcomes (ESPRITO) - Using Artificial Intelligence to Measure Adherence to Oral Medication

The aims of this project is to use an artificial intelligence (AI) smartphone app to provide support for medication adherence by patients with first episode ps…

First Episode Psychosis

Northwell HealthNCT04046497

Phase 1

Ocrelizumab for Psychoses Possibly Caused by Synaptic Autoimmunity

Some people who have what doctors currently call schizophrenia or bipolar disease may actually have a brain disease caused by auto-antibodies. Auto-antibodies …

Schizo-Affective Type of PsychosisSchizophrenia

The Methodist Hospital Research InstituteNCT03971487

Tau Networks in Psychotic Alzheimer's Disease

This research project aims to understand the brain mechanisms behind the manifestation of psychotic symptoms in Alzheimer´s disease (AD), and nature of the uni…

Alzheimer DiseaseAlzheimer Disease With DelusionsAlzheimer Disease With Psychosis

Northwell HealthNCT05847192

~$10 – $1,125

PsychosisSchizophreniaFirst-episode Psychosis

Normobaric Oxygen Therapy for Individuals With First-Episode Psychosis

Single-blind, randomized controlled trial of normobaric oxygen therapy among individuals with first-episode psychosis: Effects on symptomatology and cognition.

Nicholas BreitbordeNCT04368039

Clinical High Risk for Psychosis (CHR)

Telehealth Adaptation of Group and Family-Based Cognitive Behavioral Therapy for Youth at Risk for Psychosis

This study aims to evaluate the feasibility and effectiveness of telehealth interventions for individuals at clinical high risk for psychosis (CHR). Psychosis …

Icahn School of Medicine at Mount SinaiNCT05968560

Clinical High Risk for PsychosisUltra High Risk for Psychosis

Increasing Access to Evidence-Based CHR-P Assessment and Treatment Via Stepped-Care in Community-based Settings

This is a dissemination and implementation study that is evaluating a stepped-care intervention for identifying and treating youths at clinical high-risk for p…

University of California, DavisNCT06640803

PsychosisSchizophreniaSchizoaffective Disorder+2 more

Cluster Randomized Trial of Enhanced Coordinated Specialty Care (CSC 2.0) for Early Psychosis

The goal of this clinical trial is to compare engagement in treatment in coordinated specialty care (CSC) to five extra care elements (CSC 2.0) in first-episod…

Mclean HospitalNCT06071858

Phase 3

Lumateperone for the Improvement of Apathy in Patients With Psychotic Symptoms.

This study is looking to determine if Lumateperone improves motivation in patients with schizophrenia or schizoaffective disorders who show high levels of apat…

ApathySchizophreniaSchizophrenia; Psychosis